We live in an era where large pharma are hungry for breakthrough innovations and seek to collaborate with small biotech; and small biotech requires additional sources of capital and expertise.
o2h ChaiTime was privileged to host the world's first fireside chat with CEO of Exonate, Catherine Beech and Pete Adamson, Vice President, DAS Head, Ophthalmology, Johnson & Johnson Medical Limited.
Catherine is trained as a Medical Doctor before embarking on a career in a big pharma. She then became a venture capital investor, followed by spearheading a string of new ventures. A real wonder woman!
Pete Adamson is the Vice President, DAS Head, Ophthalmology, Johnson & Johnson Medical Limited. Prior positions include President and Head of Discovery Ophthalmology at GlaxoSmithKline.
A serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector.